Adaptimmune Therapeutics plc ADAP NASDAQ

NASDAQ Global Select • Healthcare • Biotechnology • GB • USD

SharesGrow Score

52/100

3/7 Pass

SharesGrow Intrinsic Value

Il y a eu 50 transactions d'initiés récentes enregistrées pour Adaptimmune Therapeutics plc (ADAP), dont 24 achats et 25 ventes. Le total des achats d'initiés s'élève à $1.35M et le total des ventes d'initiés à $177.48K.

Les initiés notables ayant une activité récente comprennent Bertrand William C Jr, Rawcliffe Adrian, Lunger John. Les transactions d'initiés peuvent fournir des indications sur la façon dont la direction perçoit la valorisation et les perspectives futures de l'action.

Transactions d'Initiés — ADAP

Date	Nom	Rôle	Type de Transaction	Actions	Prix Moyen	Valeur	Actions détenues
2025-02-20	Bertrand William C Jr	Chief Operating Officer	Attribution de RSU	1,074,696	$0.00	$1.4K	1,074,696
2025-02-20	Rawcliffe Adrian	Chief Executive Officer	Attribution de RSU	3,428,832	$0.00	$4.46K	3,428,832
2025-02-20	Lunger John	Chief Patient Supply Officer	Attribution de RSU	1,074,696	$0.00	$1.4K	1,074,696
2025-02-20	Norry Elliot	Chief Medical Officer	Attribution de RSU	1,074,696	$0.00	$1.4K	1,074,696
2025-02-20	Piccina Cintia	Chief Commercial Officer	Attribution de RSU	1,074,696	$0.00	$1.4K	1,074,696
2025-02-20	Brewer Joanna Elizabeth	Chief Scientific Officer	Attribution de RSU	1,074,696	$0.00	$1.4K	1,074,696
2025-01-17	Bertrand William C Jr	Chief Operating Officer	Vente Informative	5,584	$0.58	$3.24K	7,510
2025-01-17	Rawcliffe Adrian	Chief Executive Officer	Vente Informative	30,601	$0.58	$17.77K	44,327
2025-01-17	Lunger John	Chief Patient Supply Officer	Vente Informative	5,584	$0.58	$3.24K	7,510
2025-01-17	Norry Elliot	Chief Medical Officer	Vente Informative	5,584	$0.58	$3.24K	7,510
2025-01-15	Bertrand William C Jr	Chief Operating Officer	Vente Informative	9,803	$0.57	$5.63K	13,756
2025-01-15	Rawcliffe Adrian	Chief Executive Officer	Vente Informative	29,096	$0.57	$16.72K	41,582
2025-01-15	Lunger John	Chief Patient Supply Officer	Vente Informative	9,803	$0.57	$5.63K	13,756
2025-01-15	Norry Elliot	Chief Medical Officer	Vente Informative	9,803	$0.57	$5.63K	13,756
2025-01-15	Piccina Cintia	Chief Commercial Officer	Vente Informative	12,991	$0.57	$7.47K	18,421
2025-01-13	Bertrand William C Jr	Chief Operating Officer	Vente Informative	4,268	$0.59	$2.51K	5,845
2025-01-13	Rawcliffe Adrian	Chief Executive Officer	Vente Informative	12,539	$0.59	$7.37K	17,801
2025-01-13	Lunger John	Chief Patient Supply Officer	Vente Informative	4,268	$0.59	$2.51K	5,845
2025-01-13	Norry Elliot	Chief Medical Officer	Vente Informative	4,268	$0.59	$2.51K	5,845
2024-07-01	Mott David M	Director	Attribution de RSU	1,583,214	$0.16	$253.31K	1,583,214
2024-07-01	Hege Kristen	Director	Attribution de RSU	660,000	$0.16	$105.6K	660,000
2024-07-01	Allen Andrew R	Director	Attribution de RSU	660,000	$0.16	$105.6K	660,000
2024-07-01	Alleva Lawrence M	Director	Attribution de RSU	1,213,926	$0.16	$194.23K	1,213,926
2024-07-01	Menzel Garry E	Director	Attribution de RSU	1,121,604	$0.16	$179.46K	1,121,604
2024-07-01	Behbahani Ali	Director	Attribution de RSU	1,144,686	$0.16	$183.15K	1,144,686
2024-07-01	Furey John	Director	Attribution de RSU	660,000	$0.16	$105.6K	660,000
2024-07-01	Hegde Priti	Director	Attribution de RSU	1,144,686	$0.16	$183.15K	1,144,686
2024-06-18	Piccina Cintia	Chief Commercial Officer	Vente Informative	24,531	$0.93	$22.81K	38,293
2024-03-18	Piccina Cintia	Chief Commercial Officer	Attribution de RSU	1,130,832	$0.00	$1.47K	1,130,832
2024-03-08	Ecor1 Capital, Llc	10 Percent Owner	Inconnu	-	-	-	164,424,420
2024-01-17	Bertrand William C Jr	Chief Operating Officer	Vente Informative	5,309	$0.67	$3.57K	7,785
2024-01-17	Rawcliffe Adrian	Chief Executive Officer	Vente Informative	30,080	$0.67	$20.24K	44,848
2024-01-17	Lunger John	Chief Patient Supply Officer	Vente Informative	5,309	$0.67	$3.57K	7,785
2024-01-17	Norry Elliot	Chief Medical Officer	Vente Informative	5,309	$0.67	$3.57K	7,785
2024-01-16	Bertrand William C Jr	Chief Operating Officer	Vente Informative	4,681	$0.79	$3.7K	7,023
2024-01-16	Rawcliffe Adrian	Chief Executive Officer	Vente Informative	9,304	$0.79	$7.35K	14,104
2024-01-16	Lunger John	Chief Patient Supply Officer	Vente Informative	4,681	$0.79	$3.7K	7,023
2024-01-16	Norry Elliot	Chief Medical Officer	Vente Informative	2,287	$0.79	$1.81K	3,363
2024-01-15	Bertrand William C Jr	Chief Operating Officer	Attribution de RSU	565,416	$0.00	$735.04	565,416
2024-01-15	Hege Kristen	Director	Attribution de RSU	81,906	$0.14	$11.47K	81,906
2024-01-15	Rawcliffe Adrian	Chief Executive Officer	Attribution de RSU	1,696,272	$0.00	$2.21K	1,696,272
2024-01-15	Wood Gavin	Chief Financial Officer	Attribution de RSU	565,416	$0.00	$735.04	565,416
2024-01-15	Behbahani Ali	Director	Attribution de RSU	40,950	$0.14	$5.73K	40,950
2024-01-15	Tayton-martin Helen Katrina	Chief Business & Strgy Officer	Attribution de RSU	565,416	$0.00	$735.04	565,416
2024-01-15	Lunger John	Chief Patient Supply Officer	Attribution de RSU	565,416	$0.00	$735.04	565,416
2024-01-15	Norry Elliot	Chief Medical Officer	Attribution de RSU	565,416	$0.00	$735.04	565,416
2024-01-15	Brewer Joanna Elizabeth	Chief Scientific Officer	Attribution de RSU	565,416	$0.00	$735.04	565,416
2024-01-12	Bertrand William C Jr	Chief Operating Officer	Vente Informative	5,220	$0.85	$4.46K	7,874
2024-01-12	Rawcliffe Adrian	Chief Executive Officer	Vente Informative	17,257	$0.85	$14.74K	26,388
2024-01-12	Lunger John	Chief Patient Supply Officer	Vente Informative	5,220	$0.85	$4.46K	7,874

■ Informatif — transaction sur marché ouvert (la plus significative) ■ Non informatif (achat) — récompense, exercice d'option, conversion ■ Non informatif (vente) — retenue fiscale, vente à l'acquisition ■ Neutre — don, fiducie, expiration